Emerging RTP drug firm lands $9M grant to drive Alzheimer’s research
RESEARCH TRIANGLE PARK, N.C. – T3D Therapeutics, a Research Triangle Park company started with loan help from the North Carolina Biotechnology Center, has received a four-year federal grant expected to total $9 million to help study the company’s promising approach for battling Alzheimer’s disease. The grant from the National Institute on Aging, part of the National Institutes of Health, is to help fund a Phase 2 clinical trial for its leading candidate, T3D-959, an orally administered daily treatment for Alzheimer’s. The company says it expects to begin testing the drug in...
Read MoreCytonics Announces the Close of Their Regulation CF Crowdfunding Campaign with Over $530,000 in Proceeds Raised
JUPITER, FL. – Cytonics Corporation announced today that they successfully completed their Regulation CF crowdfunding campaign with over $530,000 in proceeds raised (from over 300 investors), almost double the average raise since Regulation CF was instituted in 2016. An aggressive social media marketing effort combined with an impressive track record of success, both in R&D and in sales of their APIC therapy for osteoarthritis, contributed to Cytonics’ successful capital raise. Proceeds will be used to finance a pre-clinical study for the company’s lead drug...
Read MoreCatalyst OrthoScience Closes $12.7 Million Oversubscribed Financing Round to Fuel Growth of Novel Total Shoulder System
NAPLES, FL. – Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has raised $12.7 million in an oversubscribed Series C-1 financing round led by River Cities Capital Funds (River Cities). “This funding will be instrumental in fueling rapid growth for Catalyst through increased inventory, expanded distribution and new product development,” said Brian K. Hutchison, Catalyst chairman and CEO. “The additional funding will allow us to enhance company infrastructure and hire additional talent to support our growth and...
Read MoreDurham startup 410 Medical unveils new device to improve fluid delivery
DURHAM, N.C. – Durham-based 410 Medical has launched a new and improved version of LifeFlow, its medical device for treating life-threatening low blood pressure, shock and sepsis in critically ill patients. The new version, LifeFlow Next Gen, has two new features that will allow faster and simpler fluid delivery by health care providers, the company said in a news release. “The addition of these important new features further enhances LifeFlow as the most effective tool for delivering a rapid fluid bolus,” said Kyle Chenet, chief executive officer. “At 410 our mission is to...
Read MoreNational Institutes of Health Awards Moonlight Therapeutics with a $2.5 Million Grant to Advance Development of Peanut Allergy Treatment
ATLANTA, GA. – Moonlight Therapeutics, Inc., a biotechnology company developing treatments for food allergies, announced today the receipt of $2.5 million in funding for preclinical studies and product development that will enable preparations for a clinical trial for its lead program in peanut allergy. This funding was awarded through a highly competitive Small Business Technology Transfer (STTR) Fast Track grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). Moonlight’s proprietary platform, TASIS...
Read MoreNC Biotech Center awards $1.6M to startups, life science companies, universities
RESEARCH TRIANGLE PARK, N.C. – The North Carolina Biotechnology Center awarded 37 grants and loans totaling more than $1.6 million to universities, bioscience companies and other organizations in the third quarter of its fiscal year. The awards, made from Jan. 1 to March 30, will support life science research, technology commercialization and entrepreneurship throughout North Carolina. The funding will also help universities and companies attract follow-on funding from other sources. COMPANY AWARDS Three companies received Small Business Research Loans totaling $750,000. The loan...
Read More
Follow Us!